GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Common Stock

SynBiotic SE (XTER:SBX) Common Stock : €5.01 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE Common Stock?

SynBiotic SE's quarterly common stock increased from Jun. 2022 (€4.19 Mil) to Dec. 2022 (€4.52 Mil) and increased from Dec. 2022 (€4.52 Mil) to Dec. 2023 (€5.01 Mil).

SynBiotic SE's annual common stock increased from Dec. 2021 (€3.67 Mil) to Dec. 2022 (€4.52 Mil) and increased from Dec. 2022 (€4.52 Mil) to Dec. 2023 (€5.01 Mil).

SynBiotic SE Common Stock Historical Data

The historical data trend for SynBiotic SE's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE Common Stock Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 0.25 2.63 3.67 4.52 5.01

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only 3.34 3.67 4.19 4.52 5.01

SynBiotic SE Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

SynBiotic SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Common Stock
Comparable Companies
XTER:B8FK FRA:HIGH FRA:APPH ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA XSWX:SDZ NSE:DIVISLAB NBIX SZSE:000538 ITCI VTRS HKSE:03692 NSE:TORNTPHARM TSE:4507 BOM:543904
Traded in Other Exchanges
N/A
Address
Barer Strasse 7, Munich, BY, DEU, 80333
Website
https://www.synbiotic.com
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines